Subject List - Pharmaceutical Executive

ADVERTISEMENT

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Site Content

ADVERTISEMENT

Pharmaceutical Care Management Association Releases Hep C Medicare Part D Impact Study
The Market Will Demand a Cheaper Alternative to Sovaldi
GSK Submits Malaria Vaccine Candidate for EMA Approval
Wearable Devices in Clinical Trials: Challenges and Opportunities
New "Blockbusters" Will Triple Acute Coronary Syndrome Market
PHARM EXEC DIGEST EUROPE
Pharmaceutical Executive Digest EuropeTo read the latest issue of Pharm Exec Global Digest
Click here. Click here to receive the Digest into your inbox every month.
SURVEY
The FDA Safety & Innovation Act (FDASIA) was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
30%
Breakthrough designations
15%
Protecting the supply chain
35%
Expedited reviews of drug submissions
15%
More stakeholder involvement
5%
View Results
Click here